New bifunctional Prodrugs with cleavable linker for targeted tumor therapy (ADC)
Scientists at the University of Göttingen in Germany developed new and highly potent drugs with cleavable chemical linkers to develop tumor specific antibodies for selective tumor therapy (ADC). The soluble prodrugs are activated into highly cytotoxic drugs only in targeted tumor cells.
Further information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Dr. Jens-Peter Horst
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Alle Nachrichten aus der Kategorie: Technology Offerings
Metallic state of Ag nanoclusters in oxidative dispersion identified in situ
Oxidative dispersion has been widely used in the regeneration of sintered metal catalysts as well as the fabrication of single-atom catalysts. The consensus on the oxidative dispersion process includes the…
A COSMIC approach to nanoscale science
Instrument at Berkeley Lab’s Advanced Light Source achieves world-leading resolution of nanomaterials. COSMIC, a multipurpose X-ray instrument at Lawrence Berkeley National Laboratory’s (Berkeley Lab’s) Advanced Light Source (ALS), has made…
Twistoptics – A new way to control optical nonlinearity
Columbia researchers engineer first technique to exploit the tunable symmetry of 2D materials for nonlinear optical applications, including laser, optical spectroscopy, imaging, and metrology systems, as well as next-generation optical…